Answers are grounded in this paper and cite their sources.
Basal cell carcinoma (BCC) is the most prevalent form of non-melanoma skin cancer, accounting for approximately 80% of all cases of skin cancer worldwide [ 3 ]. It primarily arises from chronic ultraviolet radiation exposure, with the incidence rising steadily in aging populations [ 3 ]. While surgical excision remains the gold standard for treatment, radiotherapy serves as the best alternative, especially in patients unsuitable for surgery due to comorbidities or tumor location [ 1 , 4 ]. Radiotherapy achieves excellent local control rates with favorable cosmetic outcomes, particularly in anatomically complex regions such as the face, nose, eyelids, and ears [ 5 , 6 , 7 ]. Postoperative radiotherapy can be recommended in patients with close or positive margins that cannot be corrected surgically due to excessive morbidity or the potential for adverse cosmetic sequelae. It is also suggested for patients who have had a relapse after previous surgery and for those with bone or muscle involvement or perineural growth around a named nerve [ 1 , 2 ].
No takes yet. Share an insight, caveat, or question.
Balermpas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: